Comparison of the Efficacy and Safety of Transarterial Chemoembolization with or without Lenvatinib for Unresectable Hepatocellular Carcinoma: A Retrospective Propensity Score–Matched Analysis

BACKGROUND: Combination of angiogenesis inhibitor may achieve better therapeutic synergistic efficacy, considering of tumor hypoxia and promoted angiogenesis after transarterial chemoembolization (TACE). This study aimed to compare the safety and efficacy of TACE plus lenvatinib (TACE-lenvatinib) wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu-Xing, Zhang, Jin-Xing, Zhou, Chun-Gao, Liu, Jin, Liu, Sheng, Shi, Hai-Bin, Zu, Qing-Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354863/
https://www.ncbi.nlm.nih.gov/pubmed/35937909
http://dx.doi.org/10.2147/JHC.S373250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354863/
https://www.ncbi.nlm.nih.gov/pubmed/35937909
http://dx.doi.org/10.2147/JHC.S373250

Ejemplares similares